9.2M
XNYS Volume
High volume today
XNYS 21 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Phyllis B Nordstrom | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.74 per share. | 17 Mar 2025 | 4,073 | 158,973 (0%) | 0% | 2.7 | 11,160 | Common Stock |
| Reji Puthenveetil | EVP, Additive Solutions & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.74 per share. | 17 Mar 2025 | 7,325 | 359,081 (0%) | 0% | 2.7 | 20,071 | Common Stock |
| Jeffrey A. Graves | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.74 per share. | 17 Mar 2025 | 18,772 | 1,073,010 (0%) | 0% | 2.7 | 51,435 | Common Stock |
| Charles W. Hull | EVP & Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.74 per share. | 17 Mar 2025 | 2,484 | 121,650 (0%) | 0% | 2.7 | 6,806 | Common Stock |
| Graves Jeffrey A. | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 3.85 per share. | 17 Dec 2024 | 60,000 | 1,091,782 (0%) | 0% | 3.9 | 231,000 | Common Stock |
| Charles Hull W. | Director, EVP & Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 3.86 per share. | 17 Dec 2024 | 115,971 | 331,955 (0%) | 0% | 3.9 | 447,648 | Common Stock |
| Currie Harriss T. | President, Regenerative Med | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.96 per share. | 16 Dec 2024 | 10,406 | 117,799 (0%) | 0% | 4.0 | 41,208 | Common Stock |
| Jeffrey D. Creech | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.97 per share. | 13 Dec 2024 | 9,804 | 167,536 (0%) | 0% | 4.0 | 38,922 | Common Stock |
| Joseph Zuiker | EVP, Engineering & Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.09 per share. | 12 Dec 2024 | 5,246 | 146,498 (0%) | 0% | 4.1 | 21,456 | Common Stock |
| Phyllis B Nordstrom | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.79 per share. | 02 Dec 2024 | 1,730 | 163,046 (0%) | 0% | 2.8 | 4,827 | Common Stock |
| Andrew William Banasick Wright | SVP, GC & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2024 | 57,500 | 57,500 (0%) | 0% | 0 | Common Stock | |
| Charles W. Hull | Director, EVP & Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2024 | 41,322 | 124,134 (0%) | 0% | 0 | Common Stock | |
| Jeffrey A. Graves | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2024 | 247,933 | 1,031,782 (0%) | 0% | 0 | Common Stock | |
| Reji Puthenveetil | EVP, Additive Solutions & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2024 | 99,173 | 366,406 (0%) | 0% | 0 | Common Stock | |
| Phyllis B Nordstrom | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2024 | 82,644 | 164,776 (0%) | 0% | 0 | Common Stock | |
| Joseph Zuiker | EVP, Engineering & Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2024 | 66,115 | 151,744 (0%) | 0% | 0 | Common Stock | |
| Jeffrey D. Creech | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2024 | 82,644 | 177,340 (0%) | 0% | 0 | Common Stock | |
| Claudia Napal Drayton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Aug 2024 | 63,084 | 99,569 (0%) | 0% | 0 | Common Stock | |
| Phyllis B Nordstrom | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.14 per share. | 30 Aug 2024 | 2,763 | 82,132 (0%) | 0% | 2.1 | 5,913 | Common Stock |
| Jim D. Kever | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Aug 2024 | 63,084 | 485,850 (0%) | 0% | 0 | Common Stock | |
| John J. Tracy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Aug 2024 | 63,084 | 151,642 (0%) | 0% | 0 | Common Stock | |
| Kevin S. Moore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Aug 2024 | 63,084 | 104,934 (0%) | 0% | 0 | Common Stock | |
| Charles G. McClure | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Aug 2024 | 63,084 | 153,048 (0%) | 0% | 0 | Common Stock | |
| Thomas W. Erickson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Aug 2024 | 63,084 | 320,378 (0%) | 0% | 0 | Common Stock | |
| Malissia R. Clinton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Aug 2024 | 63,084 | 125,869 (0%) | 0% | 0 | Common Stock | |
| Joseph Zuiker | EVP, Engineering & Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.53 per share. | 15 Apr 2024 | 5,386 | 85,629 (0%) | 0% | 3.5 | 19,013 | Common Stock |
| Phyllis B Nordstrom | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.53 per share. | 15 Apr 2024 | 8,218 | 84,895 (0%) | 0% | 3.5 | 29,010 | Common Stock |
| Reji Puthenveetil | EVP, Additive Solutions & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.53 per share. | 15 Apr 2024 | 10,926 | 267,233 (0%) | 0% | 3.5 | 38,569 | Common Stock |
| Menno Ellis | EVP, Healthcare Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.53 per share. | 15 Apr 2024 | 8,819 | 226,192 (0%) | 0% | 3.5 | 31,131 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.53 per share. | 15 Apr 2024 | 7,595 | 219,690 (0%) | 0% | 3.5 | 26,810 | Common Stock |
| Jeffrey A. Graves | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.53 per share. | 15 Apr 2024 | 30,752 | 783,849 (0%) | 0% | 3.5 | 108,555 | Common Stock |
| Charles W. Hull | Director, EVP & Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.53 per share. | 15 Apr 2024 | 3,445 | 82,812 (0%) | 0% | 3.5 | 12,161 | Common Stock |
| Jeffrey A. Graves | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.55 per share. | 15 Mar 2024 | 18,667 | 814,601 (0%) | 0% | 4.6 | 84,935 | Common Stock |
| Phyllis B Nordstrom | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.55 per share. | 15 Mar 2024 | 4,142 | 93,113 (0%) | 0% | 4.5 | 18,846 | Common Stock |
| Phyllis B Nordstrom | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.55 per share. | 15 Mar 2024 | 4,142 | 94,843 (0%) | 0% | 4.5 | 18,846 | Common Stock |
| Reji Puthenveetil | EVP, Additive Solutions & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.55 per share. | 15 Mar 2024 | 6,632 | 278,159 (0%) | 0% | 4.6 | 30,176 | Common Stock |
| Menno Ellis | EVP, Healthcare Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.55 per share. | 15 Mar 2024 | 5,354 | 235,011 (0%) | 0% | 4.6 | 24,361 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.55 per share. | 15 Mar 2024 | 4,204 | 227,285 (0%) | 0% | 4.5 | 19,128 | Common Stock |
| Charles W. Hull | Director, EVP & Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.55 per share. | 15 Mar 2024 | 2,091 | 86,257 (0%) | 0% | 4.5 | 9,514 | Common Stock |
| Jeffrey A. Graves | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.86 per share. | 16 Jan 2024 | 77,329 | 833,268 (0%) | 0% | 4.9 | 375,819 | Common Stock |
| Reji Puthenveetil | EVP, Additive Solutions & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.86 per share. | 16 Jan 2024 | 28,979 | 284,791 (0%) | 0% | 4.9 | 140,838 | Common Stock |
| Johnson Andrew M. | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.86 per share. | 16 Jan 2024 | 23,726 | 231,489 (0%) | 0% | 4.9 | 115,308 | Common Stock |
| Puthenveetil Reji | EVP, Additive Solutions & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 57,681 | 313,770 (0%) | 0% | 0 | Common Stock | |
| Charles W. Hull | Director, EVP & Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.86 per share. | 16 Jan 2024 | 13,317 | 88,348 (0%) | 0% | 4.9 | 64,721 | Common Stock |
| M. Johnson Andrew | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 49,029 | 255,215 (0%) | 0% | 0 | Common Stock | |
| Menno Ellis | EVP, Healthcare Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.86 per share. | 16 Jan 2024 | 23,583 | 240,365 (0%) | 0% | 4.9 | 114,613 | Common Stock |
| Graves A. Jeffrey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 158,622 | 910,597 (0%) | 0% | 0 | Common Stock | |
| W. Hull Charles | Director, EVP & Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 34,608 | 101,665 (0%) | 0% | 0 | Common Stock | |
| Ellis Menno | EVP, Healthcare Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 57,681 | 263,948 (0%) | 0% | 0 | Common Stock | |
| Ellis Menno | EVP, Healthcare Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.19 per share. | 12 Jan 2024 | 5,724 | 206,267 (0%) | 0% | 5.2 | 29,708 | Common Stock |
| M. Andrew Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.19 per share. | 12 Jan 2024 | 5,627 | 206,186 (0%) | 0% | 5.2 | 29,204 | Common Stock |
| Puthenveetil Reji | EVP, Additive Solutions & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.19 per share. | 12 Jan 2024 | 6,929 | 256,089 (0%) | 0% | 5.2 | 35,962 | Common Stock |
| Jeffrey Graves A. | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.19 per share. | 12 Jan 2024 | 18,519 | 751,975 (0%) | 0% | 5.2 | 96,114 | Common Stock |
| W. Charles Hull | Director, EVP & Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.19 per share. | 12 Jan 2024 | 3,136 | 67,057 (0%) | 0% | 5.2 | 16,276 | Common Stock |
| Currie T. Harriss | President, Regenerative Med | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 128,205 | 128,205 (0%) | 0% | 0 | Common Stock | |
| Creech Jeffrey | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 94,696 | 94,696 (0%) | 0% | 0 | Common Stock | |
| Joseph Zuiker | EVP, Engineering & Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.81 per share. | 12 Dec 2023 | 4,982 | 91,015 (0%) | 0% | 5.8 | 28,945 | Common Stock |
| Nordstrom Phyllis B | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.72 per share. | 02 Dec 2023 | 1,730 | 97,255 (0%) | 0% | 5.7 | 9,896 | Common Stock |
| Thomas W. Erickson | Director | Purchase of securities on an exchange or from another person at price $ 5.30 per share. | 28 Nov 2023 | 50,000 | 257,294 (0%) | 0% | 5.3 | 265,000 | Common Stock |
| Thomas W. Erickson | Director | Purchase of securities on an exchange or from another person at price $ 4.57 per share. | 21 Nov 2023 | 50,000 | 207,294 (0%) | 0% | 4.6 | 228,400 | Common Stock |
| Margaret E. Wicklund | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 48,543 | 48,543 (0%) | 0% | 0 | Common Stock | |
| Reji Puthenveetil | EVP, Industrial Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.16 per share. | 05 Oct 2023 | 67,935 | 263,018 (0%) | 0% | 4.2 | 282,610 | Common Stock |
| Reji Puthenveetil | EVP, Industrial Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2023 | 139,068 | 330,953 (0%) | 0% | 0 | Common Stock | |
| Reji Puthenveetil | EVP, Industrial Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.65 per share. | 01 Oct 2023 | 15,097 | 191,885 (0%) | 0% | 4.6 | 70,201 | Common Stock |
| Phyllis B Nordstrom | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.25 per share. | 30 Aug 2023 | 2,764 | 98,985 (0%) | 0% | 6.3 | 17,275 | Common Stock |
| Michael Turner | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.13 per share. | 29 Aug 2023 | 20,984 | 182,582 (0%) | 0% | 6.1 | 128,632 | Common Stock |
| Menno Ellis | EVP, Healthcare Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.62 per share. | 17 Jul 2023 | 1,434 | 211,991 (0%) | 0% | 9.6 | 13,795 | Common Stock |
| Phyllis B Nordstrom | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.63 per share. | 15 Jun 2023 | 4,655 | 101,749 (0%) | 0% | 9.6 | 44,828 | Common Stock |
| Reji Puthenveetil | EVP, Industrial Solutions | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 31 May 2023 | 18,434 | 206,982 (0%) | 0% | 8.0 | 147,450 | Common Stock |
| Jeffrey A. Graves | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.99 per share. | 26 May 2023 | 27,693 | 770,494 (0%) | 0% | 8.0 | 221,267 | Common Stock |
| Jim D. Kever | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 18,094 | 422,766 (0%) | 0% | 0 | Common Stock | |
| John J. Tracy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 18,094 | 88,558 (0%) | 0% | 0 | Common Stock | |
| Kevin S. Moore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 18,094 | 41,850 (0%) | 0% | 0 | Common Stock | |
| Charles G. McClure | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 18,094 | 89,964 (0%) | 0% | 0 | Common Stock | |
| William E. Curran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 18,094 | 142,503 (0%) | 0% | 0 | Common Stock | |
| Thomas W. Erickson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 18,094 | 157,294 (0%) | 0% | 0 | Common Stock | |
| Claudia Drayton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 18,094 | 36,485 (0%) | 0% | 0 | Common Stock | |
| Malissia R. Clinton | Director | Sale of securities on an exchange or to another person at price $ 8.58 per share. | 16 May 2023 | 8,685 | 62,785 (0%) | 0% | 8.6 | 74,489 | Common Stock |
| Malissia R. Clinton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 18,094 | 71,470 (0%) | 0% | 0 | Common Stock | |
| Jeffrey A. Graves | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 255,102 | 922,805 (0%) | 0% | 0 | Common Stock | |
| Jeffrey A. Graves | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.42 per share. | 11 May 2023 | 124,618 | 798,187 (0%) | 0% | 8.4 | 1,049,284 | Common Stock |
| Charles W. Hull | Director, EVP & CTO (Regenerative Med) | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2023 | 29,880 | 70,193 (0%) | 0% | 0 | Common Stock | |
| Jeffrey A. Graves | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2023 | 189,243 | 667,703 (0%) | 0% | 0 | Common Stock | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2023 | 49,800 | 211,813 (0%) | 0% | 0 | Common Stock | |
| Menno Ellis | EVP, Healthcare Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2023 | 67,231 | 213,425 (0%) | 0% | 0 | Common Stock | |
| Reji Puthenveetil | EVP, Industrial Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2023 | 67,231 | 225,416 (0%) | 0% | 0 | Common Stock | |
| Phyllis B Nordstrom | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2023 | 49,800 | 106,404 (0%) | 0% | 0 | Common Stock | |
| Michael Turner | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2023 | 74,701 | 203,566 (0%) | 0% | 0 | Common Stock | |
| Joseph Zuiker | EVP, Engineering & Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2023 | 44,820 | 95,997 (0%) | 0% | 0 | Common Stock | |
| Charles W. Hull | Director, EVP & CTO (Regenerative Med) | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.17 per share. | 15 Mar 2023 | 2,091 | 40,313 (0%) | 0% | 10.2 | 21,265 | Common Stock |
| Jeffrey A. Graves | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.17 per share. | 15 Mar 2023 | 18,706 | 478,460 (0%) | 0% | 10.2 | 190,240 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.17 per share. | 15 Mar 2023 | 4,204 | 162,013 (0%) | 0% | 10.2 | 42,755 | Common Stock |
| Menno Ellis | EVP, Healthcare Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.17 per share. | 15 Mar 2023 | 5,354 | 146,194 (0%) | 0% | 10.2 | 54,450 | Common Stock |
| Reji Puthenveetil | EVP, Industrial Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.17 per share. | 15 Mar 2023 | 5,965 | 158,185 (0%) | 0% | 10.2 | 60,664 | Common Stock |
| Phyllis B Nordstrom | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.17 per share. | 15 Mar 2023 | 4,074 | 56,604 (0%) | 0% | 10.2 | 41,433 | Common Stock |
| Charles W. Hull | Director, EVP & CTO (Regenerative Med) | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.66 per share. | 15 Feb 2023 | 3,287 | 42,404 (0%) | 0% | 11.7 | 38,326 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.66 per share. | 15 Feb 2023 | 4,718 | 166,217 (0%) | 0% | 11.7 | 55,012 | Common Stock |
| Menno Ellis | EVP, Healthcare Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.66 per share. | 15 Feb 2023 | 3,579 | 151,548 (0%) | 0% | 11.7 | 41,731 | Common Stock |
| Charles W. Hull | Director, EVP & CTO (Regenerative Med) | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.00 per share. | 12 Jan 2023 | 3,491 | 45,691 (0%) | 0% | 9 | 31,419 | Common Stock |
| Jeffrey A. Graves | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.00 per share. | 12 Jan 2023 | 18,300 | 497,166 (0%) | 0% | 9 | 164,700 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.00 per share. | 12 Jan 2023 | 5,628 | 170,935 (0%) | 0% | 9 | 50,652 | Common Stock |
| Menno Ellis | EVP, Healthcare Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.00 per share. | 12 Jan 2023 | 5,724 | 155,127 (0%) | 0% | 9 | 51,516 | Common Stock |
| Reji Puthenveetil | EVP, Industrial Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.00 per share. | 12 Jan 2023 | 5,852 | 164,150 (0%) | 0% | 9 | 52,668 | Common Stock |
| Jeffrey A. Graves | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.49 per share. | 31 Dec 2022 | 53,715 | 515,466 (0%) | 0% | 7.5 | 402,325 | Common Stock |
| Charles W. Hull | Director, EVP & CTO (Regenerative Med) | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.21 per share. | 13 Dec 2022 | 2,452 | 49,182 (0%) | 0% | 9.2 | 22,583 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.21 per share. | 13 Dec 2022 | 1,871 | 176,563 (0%) | 0% | 9.2 | 17,232 | Common Stock |
| Menno Ellis | EVP, Healthcare Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.21 per share. | 13 Dec 2022 | 1,639 | 160,851 (0%) | 0% | 9.2 | 15,095 | Common Stock |
| Joseph Zuiker | EVP, Engineering & Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2022 | 51,177 | 51,177 (0%) | 0% | 0 | Common Stock | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 9.39 per share. | 09 Dec 2022 | 7,787 | 178,434 (0%) | 0% | 9.4 | 73,120 | Common Stock |
| David K. Leigh | EVP & CTO (Additive Mfg) | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.74 per share. | 05 Dec 2022 | 3,316 | 23,977 (0%) | 0% | 9.7 | 32,298 | Common Stock |
| Phyllis B Nordstrom | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 10,672 | 51,100 (0%) | 0% | 0 | Common Stock | |
| Jeffrey A. Graves | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 9.50 per share. | 25 Nov 2022 | 10,000 | 569,181 (0%) | 0% | 9.5 | 95,000 | Common Stock |
| Jeffrey A. Graves | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 9.70 per share. | 25 Nov 2022 | 10,000 | 559,181 (0%) | 0% | 9.7 | 97,000 | Common Stock |
| Reji Puthenveetil | EVP, Industrial Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.53 per share. | 01 Oct 2022 | 12,470 | 170,002 (0%) | 0% | 8.5 | 106,369 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 10.06 per share. | 09 Sep 2022 | 6,767 | 186,221 (0%) | 0% | 10.1 | 68,076 | Common Stock |
| Wayne Pensky | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2022 | 8,849 | 9,849 (0%) | 0% | 0 | Common Stock | |
| Phyllis B Nordstrom | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.09 per share. | 30 Aug 2022 | 2,969 | 40,428 (0%) | 0% | 10.1 | 29,957 | Common Stock |
| Phyllis B Nordstrom | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.09 per share. | 30 Aug 2022 | 1,781 | 43,397 (0%) | 0% | 10.1 | 17,970 | Common Stock |
| Michael Turner | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2022 | 128,865 | 128,865 (0%) | 0% | 0 | Common Stock | |
| Menno Ellis | EVP, Healthcare Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.76 per share. | 18 Jul 2022 | 1,434 | 162,490 (0%) | 0% | 9.8 | 13,996 | Common Stock |
| David K. Leigh | EVP & CTO (Additive Mfg) | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.12 per share. | 28 Jun 2022 | 1,658 | 52,988 (0%) | 0% | 10.1 | 16,779 | Common Stock |
| Michael J. Crimmins | Former SVP and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 9,578 | 12,831 (0%) | 0% | 0 | Common Stock | |
| Phyllis B Nordstrom | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 9,578 | 60,678 (0%) | 0% | 0 | Common Stock | |
| Charles W. Hull | Director, EVP & CTO (Regenerative Med) | Sale of securities on an exchange or to another person at price $ 10.95 per share. | 08 Jun 2022 | 26,386 | 51,634 (0%) | 0% | 10.9 | 288,803 | Common Stock |
| Jeffrey A. Graves | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.56 per share. | 26 May 2022 | 27,977 | 549,181 (0%) | 0% | 10.6 | 295,437 | Common Stock |
| Jim D. Kever | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 15,015 | 394,672 (0%) | 0% | 0 | Common Stock | |
| Jim D. Kever | Director | Purchase of securities on an exchange or from another person at price $ 10.65 per share. | 24 May 2022 | 10,000 | 404,672 (0%) | 0% | 10.7 | 106,500 | Common Stock |
| John J. Tracy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 15,015 | 70,464 (0%) | 0% | 0 | Common Stock | |
| Kevin S. Moore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 15,015 | 23,756 (0%) | 0% | 0 | Common Stock | |
| Charles G. McClure | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 15,015 | 71,870 (0%) | 0% | 0 | Common Stock | |
| William E. Curran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 15,015 | 124,409 (0%) | 0% | 0 | Common Stock | |
| Michael J. Crimmins | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.99 per share. | 24 May 2022 | 953 | 22,409 (0%) | 0% | 10.0 | 9,520 | Common Stock |
| Thomas W. Erickson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 15,015 | 139,200 (0%) | 0% | 0 | Common Stock | |
| Claudia Drayton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 15,015 | 18,391 (0%) | 0% | 0 | Common Stock | |
| Malissia R. Clinton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 15,015 | 59,382 (0%) | 0% | 0 | Common Stock | |
| Malissia R. Clinton | Director | Sale of securities on an exchange or to another person at price $ 10.26 per share. | 24 May 2022 | 6,006 | 53,376 (0%) | 0% | 10.3 | 61,645 | Common Stock |
| Jeffrey A. Graves | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 10.50 per share. | 19 May 2022 | 10,141 | 577,158 (0%) | 0% | 10.5 | 106,481 | Common Stock |
| Jagtar Narula | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 16.13 per share. | 21 Mar 2022 | 5,863 | 262,054 (0%) | 0% | 16.1 | 94,570 | Common Stock |
| Reji Puthenveetil | EVP, Industrial Solutions | Sale of securities on an exchange or to another person at price $ 16.14 per share. | 21 Mar 2022 | 600 | 182,472 (0%) | 0% | 16.1 | 9,682 | Common Stock |
| Malissia R. Clinton | Director | Sale of securities on an exchange or to another person at price $ 16.08 per share. | 18 Mar 2022 | 4,375 | 44,367 (0%) | 0% | 16.1 | 70,343 | Common Stock |
| Charles W. Hull | Director, EVP & CTO (Regenerative Med) | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 18,137 | 78,020 (0%) | 0% | 0 | Common Stock | |
| Jeffrey A. Graves | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 114,873 | 567,017 (0%) | 0% | 0 | Common Stock | |
| Michael J. Crimmins | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 9,068 | 23,362 (0%) | 0% | 0 | Common Stock | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 27,206 | 192,988 (0%) | 0% | 0 | Common Stock | |
| Menno Ellis | EVP, Healthcare Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 40,810 | 163,924 (0%) | 0% | 0 | Common Stock | |
| Jagtar Narula | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 40,810 | 267,917 (0%) | 0% | 0 | Common Stock | |
| Reji Puthenveetil | EVP, Industrial Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 40,810 | 183,072 (0%) | 0% | 0 | Common Stock | |
| David K. Leigh | EVP & CTO (Additive Mfg) | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 25,695 | 54,646 (0%) | 0% | 0 | Common Stock | |
| Phyllis B Nordstrom | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 22,672 | 45,178 (0%) | 0% | 0 | Common Stock | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 14.84 per share. | 10 Mar 2022 | 5,000 | 165,782 (0%) | 0% | 14.8 | 74,205 | Common Stock |
| Jeffrey A. Graves | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 14.76 per share. | 09 Mar 2022 | 40,837 | 452,144 (0%) | 0% | 14.8 | 602,738 | Common Stock |
| Jagtar Narula | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.16 per share. | 09 Mar 2022 | 11,878 | 227,107 (0%) | 0% | 15.2 | 180,065 | Common Stock |
| Claudia Drayton | Director | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 08 Mar 2022 | 3,376 | 3,376 (0%) | 0% | 15 | 50,640 | Common Stock |
| Charles W. Hull | Director, EVP & CTO (Regenerative Med) | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 23,516 | 83,399 (0%) | 0% | 0 | Common Stock | |
| Charles W. Hull | Director, EVP & CTO (Regenerative Med) | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.81 per share. | 03 Mar 2022 | 10,290 | 73,109 (0%) | 0% | 15.8 | 162,685 | Common Stock |
| Jeffrey A. Graves | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.81 per share. | 03 Mar 2022 | 39,789 | 492,981 (0%) | 0% | 15.8 | 629,064 | Common Stock |
| Jeffrey A. Graves | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 80,626 | 532,770 (0%) | 0% | 0 | Common Stock | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.81 per share. | 03 Mar 2022 | 10,166 | 170,782 (0%) | 0% | 15.8 | 160,724 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 21,933 | 180,948 (0%) | 0% | 0 | Common Stock | |
| Menno Ellis | EVP, Healthcare Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.81 per share. | 03 Mar 2022 | 9,229 | 123,114 (0%) | 0% | 15.8 | 145,910 | Common Stock |
| Menno Ellis | EVP, Healthcare Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 23,453 | 132,343 (0%) | 0% | 0 | Common Stock | |
| Jagtar Narula | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.81 per share. | 03 Mar 2022 | 11,575 | 238,985 (0%) | 0% | 15.8 | 183,001 | Common Stock |
| Jagtar Narula | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 23,453 | 250,560 (0%) | 0% | 0 | Common Stock | |
| Reji Puthenveetil | EVP, Industrial Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 23,453 | 152,664 (0%) | 0% | 0 | Common Stock | |
| Reji Puthenveetil | EVP, Industrial Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.81 per share. | 03 Mar 2022 | 10,402 | 142,262 (0%) | 0% | 15.8 | 164,456 | Common Stock |
| David K. Leigh | EVP & CTO (Additive Mfg) | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.81 per share. | 03 Mar 2022 | 2,978 | 28,951 (0%) | 0% | 15.8 | 47,082 | Common Stock |
| David K. Leigh | EVP & CTO (Additive Mfg) | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 10,878 | 31,929 (0%) | 0% | 0 | Common Stock | |
| Phyllis B Nordstrom | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.81 per share. | 03 Mar 2022 | 2,440 | 22,506 (0%) | 0% | 15.8 | 38,576 | Common Stock |
| Phyllis B Nordstrom | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 4,476 | 24,946 (0%) | 0% | 0 | Common Stock | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 01 Mar 2022 | 4,000 | 159,015 (0%) | 0% | 20 | 80,000 | Common Stock |
| Jagtar Narula | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 16.95 per share. | 22 Feb 2022 | 5,863 | 227,107 (0%) | 0% | 17.0 | 99,378 | Common Stock |
| Reji Puthenveetil | EVP, Industrial Solutions | Sale of securities on an exchange or to another person at price $ 16.98 per share. | 22 Feb 2022 | 600 | 129,211 (0%) | 0% | 17.0 | 10,185 | Common Stock |
| Charles W. Hull | Director, EVP & CTO (Regenerative Med) | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.38 per share. | 15 Feb 2022 | 3,515 | 59,883 (0%) | 0% | 19.4 | 68,121 | Common Stock |
| Charles W. Hull | Director, EVP & CTO (Regenerative Med) | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.38 per share. | 15 Feb 2022 | 2,140 | 63,398 (0%) | 0% | 19.4 | 41,473 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.38 per share. | 15 Feb 2022 | 3,671 | 167,686 (0%) | 0% | 19.4 | 71,144 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.38 per share. | 15 Feb 2022 | 4,671 | 163,015 (0%) | 0% | 19.4 | 90,524 | Common Stock |
| Menno Ellis | EVP, Healthcare Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.38 per share. | 15 Feb 2022 | 3,608 | 108,890 (0%) | 0% | 19.4 | 69,923 | Common Stock |
| Menno Ellis | EVP, Healthcare Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.38 per share. | 15 Feb 2022 | 2,397 | 112,498 (0%) | 0% | 19.4 | 46,454 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 18.50 per share. | 01 Feb 2022 | 4,000 | 171,357 (0%) | 0% | 18.5 | 74,000 | Common Stock |
| Jagtar Narula | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.99 per share. | 21 Jan 2022 | 5,863 | 232,970 (0%) | 0% | 18.0 | 105,475 | Common Stock |
| Reji Puthenveetil | EVP, Industrial Solutions | Sale of securities on an exchange or to another person at price $ 17.77 per share. | 21 Jan 2022 | 600 | 129,811 (0%) | 0% | 17.8 | 10,661 | Common Stock |
| Charles W. Hull | Director, EVP & CTO (Regenerative Med) | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.18 per share. | 12 Jan 2022 | 5,299 | 65,538 (0%) | 0% | 20.2 | 106,934 | Common Stock |
| Charles W. Hull | Director, EVP & CTO (Regenerative Med) | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.18 per share. | 12 Jan 2022 | 3,119 | 70,837 (0%) | 0% | 20.2 | 62,941 | Common Stock |
| Jeffrey A. Graves | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.18 per share. | 12 Jan 2022 | 17,759 | 452,144 (0%) | 0% | 20.2 | 358,377 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.18 per share. | 12 Jan 2022 | 5,347 | 175,357 (0%) | 0% | 20.2 | 107,902 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.18 per share. | 12 Jan 2022 | 5,413 | 180,704 (0%) | 0% | 20.2 | 109,234 | Common Stock |
| Menno Ellis | EVP, Healthcare Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.18 per share. | 12 Jan 2022 | 5,407 | 114,895 (0%) | 0% | 20.2 | 109,113 | Common Stock |
| Jagtar Narula | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.18 per share. | 12 Jan 2022 | 6,689 | 238,833 (0%) | 0% | 20.2 | 134,984 | Common Stock |
| Reji Puthenveetil | EVP, Industrial Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.18 per share. | 12 Jan 2022 | 6,048 | 130,411 (0%) | 0% | 20.2 | 122,049 | Common Stock |
| Jeffrey A. Graves | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.54 per share. | 31 Dec 2021 | 53,715 | 469,903 (0%) | 0% | 21.5 | 1,157,021 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 21.81 per share. | 27 Dec 2021 | 4,000 | 186,117 (0%) | 0% | 21.8 | 87,240 | Common Stock |
| Jagtar Narula | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 21.50 per share. | 21 Dec 2021 | 5,863 | 245,522 (0%) | 0% | 21.5 | 126,055 | Common Stock |
| Charles W. Hull | Director, EVP & CTO (Regenerative Med) | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.33 per share. | 13 Dec 2021 | 1,651 | 73,956 (0%) | 0% | 21.3 | 35,216 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.33 per share. | 13 Dec 2021 | 1,871 | 190,117 (0%) | 0% | 21.3 | 39,908 | Common Stock |
| Menno Ellis | EVP, Healthcare Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.33 per share. | 13 Dec 2021 | 1,639 | 120,302 (0%) | 0% | 21.3 | 34,960 | Common Stock |
| Claudia Drayton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2021 | 6,752 | 6,752 (0%) | 0% | - | Common Stock | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 22.57 per share. | 26 Nov 2021 | 4,000 | 191,988 (0%) | 0% | 22.6 | 90,280 | Common Stock |
| Jagtar Narula | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 24.40 per share. | 22 Nov 2021 | 5,863 | 251,385 (0%) | 0% | 24.4 | 143,057 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 28.71 per share. | 26 Oct 2021 | 4,000 | 195,988 (0%) | 0% | 28.7 | 114,840 | Common Stock |
| Reji Puthenveetil | EVP, Industrial Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.67 per share. | 01 Oct 2021 | 14,634 | 136,459 (0%) | 0% | 27.7 | 404,923 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 29.10 per share. | 27 Sep 2021 | 4,000 | 199,988 (0%) | 0% | 29.1 | 116,400 | Common Stock |
| Jagtar Narula | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.88 per share. | 14 Sep 2021 | 71,407 | 257,248 (0%) | 0% | 29.9 | 2,133,641 | Common Stock |
| Phyllis B Nordstrom | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Aug 2021 | 3,411 | 3,411 (0%) | 0% | 0 | Common Stock | |
| Phyllis B Nordstrom | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Aug 2021 | 17,059 | 20,470 (0%) | 0% | 0 | Common Stock | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 29.41 per share. | 26 Aug 2021 | 4,000 | 203,988 (0%) | 0% | 29.4 | 117,640 | Common Stock |
| Jeffrey A. Graves | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 29.37 per share. | 16 Aug 2021 | 4,260 | 523,618 (0%) | 0% | 29.4 | 125,116 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 25.80 per share. | 26 Jul 2021 | 4,000 | 207,988 (0%) | 0% | 25.8 | 103,200 | Common Stock |
| Menno Ellis | EVP, Healthcare Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.90 per share. | 17 Jul 2021 | 1,372 | 121,941 (0%) | 0% | 25.9 | 35,535 | Common Stock |
| David K. Leigh | EVP & CTO (Additive Mfg) | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2021 | 20,421 | 21,051 (0%) | 0% | 0 | Common Stock | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 38.20 per share. | 25 Jun 2021 | 4,000 | 211,988 (0%) | 0% | 38.2 | 152,800 | Common Stock |
| Jeff Blank | EVP, Engineering and Prod Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.35 per share. | 13 Jun 2021 | 985 | 51,229 (0%) | 0% | 29.4 | 28,910 | Common Stock |
| Jeffrey A. Graves | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.37 per share. | 26 May 2021 | 27,977 | 519,358 (0%) | 0% | 29.4 | 821,684 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 27.29 per share. | 26 May 2021 | 4,000 | 215,988 (0%) | 0% | 27.3 | 109,160 | Common Stock |
| Michael J. Crimmins | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2021 | 9,114 | 9,114 (0%) | 0% | 0 | Common Stock | |
| Jeffrey A. Graves | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 24.71 per share. | 19 May 2021 | 4,100 | 547,335 (0%) | 0% | 24.7 | 101,311 | Common Stock |
| Jim D. Kever | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 6,007 | 379,657 (0%) | 0% | 0 | Common Stock | |
| John J. Tracy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 6,007 | 55,449 (0%) | 0% | 0 | Common Stock | |
| Kevin S. Moore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 6,007 | 8,741 (0%) | 0% | 0 | Common Stock | |
| William D. Humes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 6,007 | 68,573 (0%) | 0% | 0 | Common Stock | |
| William E. Curran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 6,007 | 109,394 (0%) | 0% | 0 | Common Stock | |
| Thomas W. Erickson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 6,007 | 124,185 (0%) | 0% | 0 | Common Stock | |
| Malissia R. Clinton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 6,007 | 48,742 (0%) | 0% | 0 | Common Stock | |
| Menno Ellis | EVP, Healthcare Solutions | Sale of securities on an exchange or to another person at price $ 22.49 per share. | 17 May 2021 | 10,573 | 123,313 (0%) | 0% | 22.5 | 237,787 | Common Stock |
| Jeff Blank | EVP, Engineering and Prod Dev | Sale of securities on an exchange or to another person at price $ 21.90 per share. | 14 May 2021 | 10,000 | 53,832 (0%) | 0% | 21.9 | 219,000 | Common Stock |
| Jeff Blank | EVP, Engineering and Prod Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.71 per share. | 14 May 2021 | 1,618 | 52,214 (0%) | 0% | 22.7 | 36,745 | Common Stock |
| Charles W. Hull | Director, EVP & CTO (Regenerative Med) | Sale of securities on an exchange or to another person at price $ 14.78 per share. | 07 Mar 2021 | 16,389 | 447,926 (0%) | 0% | 14.8 | 242,298 | Common Stock |
| Charles W. Hull | Director, EVP & CTO (Regenerative Med) | Sale of securities on an exchange or to another person at price $ 14.77 per share. | 07 Mar 2021 | 13,226 | 59,883 (0%) | 0% | 14.8 | 195,352 | Common Stock |
| Michael J. Crimmins | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.81 per share. | 03 Mar 2021 | 2,862 | 14,294 (0%) | 0% | 15.8 | 45,248 | Common Stock |
| Michael J. Crimmins | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 8,042 | 17,156 (0%) | 0% | 0 | Common Stock | |
| Charles W. Hull | Director, EVP & Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.79 per share. | 01 Mar 2021 | 1,085 | 150,117 (0%) | 0% | 38.8 | 42,087 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.79 per share. | 01 Mar 2021 | 1,652 | 219,988 (0%) | 0% | 38.8 | 64,081 | Common Stock |
| Menno Ellis | EVP, Healthcare Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.79 per share. | 01 Mar 2021 | 879 | 133,886 (0%) | 0% | 38.8 | 34,096 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 23 Feb 2021 | 4,000 | 221,640 (0%) | 0% | 35 | 140,000 | Common Stock |
| Charles W. Hull | Director, EVP & Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.85 per share. | 16 Feb 2021 | 2,014 | 154,320 (0%) | 0% | 47.9 | 96,370 | Common Stock |
| Charles W. Hull | Director, EVP & Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.85 per share. | 16 Feb 2021 | 3,118 | 151,202 (0%) | 0% | 47.8 | 149,196 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.85 per share. | 16 Feb 2021 | 3,614 | 230,109 (0%) | 0% | 47.9 | 172,930 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.85 per share. | 16 Feb 2021 | 4,469 | 225,640 (0%) | 0% | 47.9 | 213,842 | Common Stock |
| Menno Ellis | EVP, Healthcare Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.85 per share. | 16 Feb 2021 | 3,424 | 134,765 (0%) | 0% | 47.8 | 163,838 | Common Stock |
| Menno Ellis | EVP, Healthcare Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.85 per share. | 16 Feb 2021 | 2,373 | 138,189 (0%) | 0% | 47.8 | 113,548 | Common Stock |
| Jeff Blank | EVP, Engineering and Prod Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.85 per share. | 16 Feb 2021 | 826 | 63,832 (0%) | 0% | 47.8 | 39,524 | Common Stock |
| Anthony Grabenau | Former PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2021 | 2,500 | 17,533 (0%) | 0% | 0 | Common Stock | |
| Anthony Grabenau | Former PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2021 | 5,533 | 15,033 (0%) | 0% | 0 | Common Stock | |
| Jeffrey A. Graves | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.91 per share. | 01 Feb 2021 | 5,222 | 543,235 (0%) | 0% | 38.9 | 203,188 | Common Stock |
| Jeffrey A. Graves | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 10,389 | 548,457 (0%) | 0% | 0 | Common Stock | |
| Jagtar Narula | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 1,530 | 329,373 (0%) | 0% | 0 | Common Stock | |
| Jagtar Narula | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.91 per share. | 01 Feb 2021 | 718 | 328,655 (0%) | 0% | 38.9 | 27,937 | Common Stock |
| Reji Puthenveetil | EVP, Industrial Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 1,292 | 151,688 (0%) | 0% | 0 | Common Stock | |
| Reji Puthenveetil | EVP, Industrial Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.91 per share. | 01 Feb 2021 | 595 | 151,093 (0%) | 0% | 38.9 | 23,151 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 30.10 per share. | 22 Jan 2021 | 4,000 | 233,723 (0%) | 0% | 30.1 | 120,400 | Common Stock |
| Charles W. Hull | Director, EVP & Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2021 | 15,381 | 156,334 (0%) | 0% | 0 | Common Stock | |
| Charles W. Hull | Director, EVP & Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2021 | 23,072 | 140,953 (0%) | 0% | 0 | Common Stock | |
| Jeffrey A. Graves | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2021 | 105,748 | 538,068 (0%) | 0% | 0 | Common Stock | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2021 | 32,686 | 226,187 (0%) | 0% | 0 | Common Stock | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2021 | 11,536 | 237,723 (0%) | 0% | 0 | Common Stock | |
| Menno Ellis | EVP, Healthcare Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2021 | 38,454 | 140,562 (0%) | 0% | 0 | Common Stock | |
| Jagtar Narula | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2021 | 38,454 | 327,843 (0%) | 0% | 0 | Common Stock | |
| Reji Puthenveetil | EVP, Industrial Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2021 | 38,454 | 150,396 (0%) | 0% | 0 | Common Stock | |
| Jeff Blank | EVP, Engineering and Prod Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2021 | 15,381 | 64,658 (0%) | 0% | 0 | Common Stock | |
| Jeffrey A. Graves | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.48 per share. | 31 Dec 2020 | 26,856 | 432,320 (0%) | 0% | 10.5 | 281,451 | Common Stock |
| Malissia R. Clinton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2020 | 3,647 | 42,735 (0%) | 0% | 0 | Common Stock | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 11.94 per share. | 23 Dec 2020 | 4,000 | 193,501 (0%) | 0% | 11.9 | 47,760 | Common Stock |
| Charles W. Hull | Director, EVP & Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.36 per share. | 14 Dec 2020 | 3,141 | 117,881 (0%) | 0% | 10.4 | 32,541 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.36 per share. | 14 Dec 2020 | 2,450 | 197,501 (0%) | 0% | 10.4 | 25,382 | Common Stock |
| Menno Ellis | EVP, Healthcare Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.36 per share. | 14 Dec 2020 | 2,028 | 102,108 (0%) | 0% | 10.4 | 21,010 | Common Stock |
| Menno Ellis | EVP, Healthcare Solutions | Sale of securities on an exchange or to another person at price $ 10.44 per share. | 04 Dec 2020 | 10,479 | 104,136 (0%) | 0% | 10.4 | 109,401 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 24 Nov 2020 | 4,000 | 199,951 (0%) | 0% | 8 | 32,000 | Common Stock |
| Anthony Grabenau | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2020 | 9,500 | 9,500 (0%) | 0% | 0 | Common Stock | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 22 Oct 2020 | 16,000 | 207,951 (0%) | 0% | 8 | 128,000 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 8.36 per share. | 22 Oct 2020 | 4,000 | 203,951 (0%) | 0% | 8.4 | 33,440 | Common Stock |
| Reji Puthenveetil | EVP, Industrial Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2020 | 19,230 | 19,230 (0%) | 0% | 0 | Common Stock | |
| Reji Puthenveetil | EVP, Industrial Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2020 | 92,712 | 111,942 (0%) | 0% | 0 | Common Stock | |
| Jim D. Kever | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Sep 2020 | 15,209 | 373,650 (0%) | 0% | 0 | Common Stock | |
| John J. Tracy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Sep 2020 | 15,209 | 49,442 (0%) | 0% | 0 | Common Stock | |
| Jeffrey Wadsworth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Sep 2020 | 15,209 | 50,848 (0%) | 0% | 0 | Common Stock | |
| Kevin S. Moore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Sep 2020 | 15,209 | 17,943 (0%) | 0% | 0 | Common Stock | |
| Charles G. McClure | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Sep 2020 | 15,209 | 50,848 (0%) | 0% | 0 | Common Stock | |
| William D. Humes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Sep 2020 | 15,209 | 62,566 (0%) | 0% | 0 | Common Stock | |
| William E. Curran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Sep 2020 | 15,209 | 103,387 (0%) | 0% | 0 | Common Stock | |
| Thomas W. Erickson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Sep 2020 | 15,209 | 118,178 (0%) | 0% | 0 | Common Stock | |
| Malissia R. Clinton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Sep 2020 | 15,209 | 39,088 (0%) | 0% | 0 | Common Stock | |
| Jagtar Narula | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2020 | 332,901 | 332,901 (0%) | 0% | 0 | Common Stock | |
| Jagtar Narula | EVP & Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Sep 2020 | 289,389 | 289,389 (0%) | 0% | 0 | Common Stock | |
| Jeffrey A. Graves | President and CEO | Purchase of securities on an exchange or from another person at price $ 5.39 per share. | 04 Sep 2020 | 17,000 | 459,176 (0%) | 0% | 5.4 | 91,598 | Common Stock |
| Wayne Pensky | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2020 | 16,329 | 16,329 (0%) | 0% | 0 | Common Stock | |
| Charles W. Hull | Director, EVP & Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.81 per share. | 17 Aug 2020 | 2,629 | 121,022 (0%) | 0% | 5.8 | 15,274 | Common Stock |
| Jim D. Kever | Director | Purchase of securities on an exchange or from another person at price $ 5.80 per share. | 17 Aug 2020 | 10,000 | 358,441 (0%) | 0% | 5.8 | 58,000 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.81 per share. | 17 Aug 2020 | 2,740 | 223,951 (0%) | 0% | 5.8 | 15,919 | Common Stock |
| Sadie Stern | EVP, People and Culture | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.81 per share. | 17 Aug 2020 | 1,972 | 94,378 (0%) | 0% | 5.8 | 11,457 | Common Stock |
| Menno Ellis | EVP, Healthcare Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.81 per share. | 17 Aug 2020 | 1,388 | 114,615 (0%) | 0% | 5.8 | 8,064 | Common Stock |
| Menno Ellis | EVP, Healthcare Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2020 | 10,932 | 116,003 (0%) | 0% | 0 | Common Stock | |
| Philip C. Schultz | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.58 per share. | 15 Jun 2020 | 1,403 | 154,897 (0%) | 0% | 7.6 | 10,635 | Common Stock |
| Sadie Stern | EVP, People and Culture | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.58 per share. | 15 Jun 2020 | 702 | 96,350 (0%) | 0% | 7.6 | 5,321 | Common Stock |
| Radhika Krishnan | EVP, Software and Healthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.58 per share. | 15 Jun 2020 | 1,403 | 97,616 (0%) | 0% | 7.6 | 10,635 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 28 May 2020 | 4,000 | 226,691 (0%) | 0% | 8 | 32,000 | Common Stock |
| Jeffrey A. Graves | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2020 | 272,108 | 272,108 (0%) | 0% | 0 | Common Stock | |
| Jeffrey A. Graves | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2020 | 170,068 | 442,176 (0%) | 0% | 0 | Common Stock | |
| Jim D. Kever | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2020 | 10,000 | 348,441 (0%) | 0% | 0 | Common Stock | |
| John J. Tracy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2020 | 10,000 | 34,233 (0%) | 0% | 0 | Common Stock | |
| Jeffrey Wadsworth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2020 | 10,000 | 35,639 (0%) | 0% | 0 | Common Stock | |
| Kevin S. Moore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2020 | 10,000 | 122,484 (0%) | 0% | 0 | Common Stock | |
| Charles G. McClure | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2020 | 10,000 | 35,639 (0%) | 0% | 0 | Common Stock | |
| William D. Humes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2020 | 10,000 | 47,357 (0%) | 0% | 0 | Common Stock | |
| William E. Curran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2020 | 10,000 | 88,178 (0%) | 0% | 0 | Common Stock | |
| Thomas W. Erickson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2020 | 10,000 | 102,969 (0%) | 0% | 0 | Common Stock | |
| Malissia R. Clinton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2020 | 10,000 | 23,879 (0%) | 0% | 0 | Common Stock | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 24 Apr 2020 | 4,000 | 230,691 (0%) | 0% | 8 | 32,000 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 30 Mar 2020 | 4,000 | 234,691 (0%) | 0% | 8 | 32,000 | Common Stock |
| Radhika Krishnan | EVP, Software and Healthcare | Sale of securities on an exchange or to another person at price $ 9.41 per share. | 03 Mar 2020 | 6,542 | 99,019 (0%) | 0% | 9.4 | 61,557 | Common Stock |
| Charles W. Hull | Director, EVP & Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.53 per share. | 02 Mar 2020 | 1,121 | 121,238 (0%) | 0% | 9.5 | 10,683 | Common Stock |
| Charles W. Hull | Director, EVP & Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 3,639 | 124,877 (0%) | 0% | 0 | Common Stock | |
| Charles W. Hull | Director, EVP & Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.53 per share. | 02 Mar 2020 | 1,226 | 123,651 (0%) | 0% | 9.5 | 11,684 | Common Stock |
| Vyomesh I. Joshi | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.53 per share. | 02 Mar 2020 | 5,422 | 182,059 (0%) | 0% | 9.5 | 51,672 | Common Stock |
| Vyomesh I. Joshi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 17,295 | 199,354 (0%) | 0% | 0 | Common Stock | |
| Vyomesh I. Joshi | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.53 per share. | 02 Mar 2020 | 5,981 | 193,373 (0%) | 0% | 9.5 | 56,999 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.53 per share. | 02 Mar 2020 | 1,097 | 238,691 (0%) | 0% | 9.5 | 10,454 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 9.58 per share. | 02 Mar 2020 | 3,234 | 238,691 (0%) | 0% | 9.6 | 30,967 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 3,234 | 241,925 (0%) | 0% | 0 | Common Stock | |
| Herbert Koeck | EVP, Global Go-To-Market | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 4,583 | 106,301 (0%) | 0% | 0 | Common Stock | |
| Herbert Koeck | EVP, Global Go-To-Market | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.53 per share. | 02 Mar 2020 | 1,478 | 104,823 (0%) | 0% | 9.5 | 14,085 | Common Stock |
| Herbert Koeck | EVP, Global Go-To-Market | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.53 per share. | 02 Mar 2020 | 1,517 | 101,718 (0%) | 0% | 9.5 | 14,457 | Common Stock |
| Philip C. Schultz | EVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 3,730 | 160,030 (0%) | 0% | 0 | Common Stock | |
| Philip C. Schultz | EVP, Operations | Sale of securities on an exchange or to another person at price $ 9.58 per share. | 02 Mar 2020 | 3,730 | 156,300 (0%) | 0% | 9.6 | 35,733 | Common Stock |
| Philip C. Schultz | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.53 per share. | 02 Mar 2020 | 1,325 | 156,300 (0%) | 0% | 9.5 | 12,627 | Common Stock |
| Todd A. Booth | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 1,437 | 160,909 (0%) | 0% | 0 | Common Stock | |
| Todd A. Booth | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.53 per share. | 02 Mar 2020 | 272 | 160,637 (0%) | 0% | 9.5 | 2,592 | Common Stock |
| Sadie Stern | EVP, People and Culture | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.53 per share. | 02 Mar 2020 | 887 | 97,052 (0%) | 0% | 9.5 | 8,453 | Common Stock |
| Sadie Stern | EVP, People and Culture | Sale of securities on an exchange or to another person at price $ 9.58 per share. | 02 Mar 2020 | 3,178 | 97,052 (0%) | 0% | 9.6 | 30,445 | Common Stock |
| Sadie Stern | EVP, People and Culture | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 3,178 | 100,230 (0%) | 0% | 0 | Common Stock | |
| Radhika Krishnan | EVP, Software and Healthcare | Sale of securities on an exchange or to another person at price $ 9.57 per share. | 02 Mar 2020 | 3,630 | 105,561 (0%) | 0% | 9.6 | 34,757 | Common Stock |
| Radhika Krishnan | EVP, Software and Healthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 3,630 | 109,191 (0%) | 0% | 0 | Common Stock | |
| Charles W. Hull | Director, EVP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 80,000 | 80,000 | - | - | Stock Appreciation Right | |
| Charles W. Hull | Director, EVP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.13 per share. | 18 Feb 2020 | 2,238 | 95,314 (0%) | 0% | 12.1 | 27,147 | Common Stock |
| Charles W. Hull | Director, EVP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 27,045 | 122,359 (0%) | 0% | 0 | Common Stock | |
| Charles W. Hull | Director, EVP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 80,000 | 160,000 | - | - | Stock Appreciation Right | |
| Vyomesh I. Joshi | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.13 per share. | 18 Feb 2020 | 9,441 | 187,481 (0%) | 0% | 12.1 | 114,519 | Common Stock |
| Vyomesh I. Joshi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 250,000 | 250,000 | - | - | Stock Appreciation Right | |
| Vyomesh I. Joshi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 250,000 | 500,000 | - | - | Stock Appreciation Right | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 30,227 | 239,788 (0%) | 0% | 0 | Common Stock | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 80,000 | 160,000 | - | - | Stock Appreciation Right | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 80,000 | 80,000 | - | - | Stock Appreciation Right | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.13 per share. | 18 Feb 2020 | 2,763 | 209,561 (0%) | 0% | 12.1 | 33,515 | Common Stock |
| Herbert Koeck | EVP, Global Go To Market | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 10,909 | 103,235 (0%) | 0% | 0 | Common Stock | |
| Herbert Koeck | EVP, Global Go To Market | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 70,000 | 140,000 | - | - | Stock Appreciation Right | |
| Herbert Koeck | EVP, Global Go To Market | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 70,000 | 70,000 | - | - | Stock Appreciation Right | |
| Herbert Koeck | EVP, Global Go To Market | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.13 per share. | 18 Feb 2020 | 2,590 | 92,326 (0%) | 0% | 12.1 | 31,417 | Common Stock |
| Philip C. Schultz | EVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 33,636 | 157,625 (0%) | 0% | 0 | Common Stock | |
| Philip C. Schultz | EVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 50,000 | 50,000 | - | - | Stock Appreciation Right | |
| Philip C. Schultz | EVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 50,000 | 100,000 | - | - | Stock Appreciation Right | |
| Philip C. Schultz | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.13 per share. | 18 Feb 2020 | 3,306 | 123,989 (0%) | 0% | 12.1 | 40,102 | Common Stock |
| Todd A. Booth | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 37,955 | 159,472 (0%) | 0% | 0 | Common Stock | |
| Sadie Stern | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 19,773 | 97,939 (0%) | 0% | 0 | Common Stock | |
| Sadie Stern | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.13 per share. | 18 Feb 2020 | 2,488 | 78,166 (0%) | 0% | 12.1 | 30,179 | Common Stock |
| Radhika Krishnan | EVP, Healthcare and Software | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 23,409 | 105,561 (0%) | 0% | 0 | Common Stock | |
| Radhika Krishnan | EVP, Healthcare and Software | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.13 per share. | 18 Feb 2020 | 1,495 | 82,152 (0%) | 0% | 12.1 | 18,134 | Common Stock |
| Charles W. Hull | Director, EVP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2019 | 18,165 | 97,552 (0%) | 0% | 0 | Common Stock | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2019 | 16,144 | 212,324 (0%) | 0% | 0 | Common Stock | |
| Herbert Koeck | EVP, Global Go To Market | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2019 | 22,876 | 94,916 (0%) | 0% | 0 | Common Stock | |
| Philip C. Schultz | EVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2019 | 34,909 | 115,130 (0%) | 0% | 0 | Common Stock | |
| Todd A. Booth | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2019 | 21,517 | 121,517 (0%) | 0% | 0 | Common Stock | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 9.62 per share. | 06 Nov 2019 | 20,068 | 196,180 (0%) | 0% | 9.6 | 193,054 | Common Stock |
| Charles W. Hull | Director, EVP, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 9.73 per share. | 05 Nov 2019 | 41,940 | 79,387 (0%) | 0% | 9.7 | 408,076 | Common Stock |
| Herbert Koeck | EVP, Global Go To Market | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.44 per share. | 06 Sep 2019 | 5,372 | 30,423 (0%) | 0% | 7.4 | 39,968 | Common Stock |
| Philip C. Schultz | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.44 per share. | 06 Sep 2019 | 4,035 | 80,221 (0%) | 0% | 7.4 | 30,020 | Common Stock |
| Todd A. Booth | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2019 | 100,000 | 100,000 (0%) | 0% | 0 | Common Stock | |
| Charles W. Hull | Director, EVP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.55 per share. | 15 Aug 2019 | 2,629 | 121,327 (0%) | 0% | 6.6 | 17,220 | Common Stock |
| John N. McMullen | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.55 per share. | 15 Aug 2019 | 3,944 | 120,773 (0%) | 0% | 6.5 | 25,833 | Common Stock |
| Vyomesh I. Joshi | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.55 per share. | 15 Aug 2019 | 13,144 | 287,450 (0%) | 0% | 6.5 | 86,093 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.55 per share. | 15 Aug 2019 | 2,740 | 216,248 (0%) | 0% | 6.6 | 17,947 | Common Stock |
| Herbert Koeck | EVP, Global Go To Market | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.55 per share. | 15 Aug 2019 | 3,676 | 35,795 (0%) | 0% | 6.6 | 24,078 | Common Stock |
| Philip C. Schultz | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.55 per share. | 15 Aug 2019 | 3,287 | 84,256 (0%) | 0% | 6.6 | 21,530 | Common Stock |
| Charles W. Hull | Director, EVP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.07 per share. | 26 Jul 2019 | 5,764 | 123,956 (0%) | 0% | 9.1 | 52,279 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.07 per share. | 26 Jul 2019 | 5,059 | 218,988 (0%) | 0% | 9.1 | 45,885 | Common Stock |
| John N. McMullen | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.09 per share. | 01 Jul 2019 | 8,646 | 124,717 (0%) | 0% | 9.1 | 78,592 | Common Stock |
| Philip C. Schultz | EVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 12,165 | 127,295 (0%) | 0% | 0 | Common Stock | |
| Jim D. Kever | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2019 | 11,455 | 338,441 (0%) | 0% | - | Common Stock | |
| John J. Tracy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2019 | 11,455 | 24,233 (0%) | 0% | - | Common Stock | |
| Jeffrey Wadsworth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2019 | 11,455 | 25,639 (0%) | 0% | - | Common Stock | |
| Kevin S. Moore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2019 | 11,455 | 112,484 (0%) | 0% | - | Common Stock | |
| Charles G. McClure | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2019 | 11,455 | 25,639 (0%) | 0% | - | Common Stock | |
| William D. Humes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2019 | 11,455 | 37,357 (0%) | 0% | - | Common Stock | |
| William E. Curran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2019 | 11,455 | 78,178 (0%) | 0% | - | Common Stock | |
| Thomas W. Erickson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2019 | 11,455 | 92,969 (0%) | 0% | - | Common Stock | |
| Malissia R. Clinton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2019 | 11,455 | 13,879 (0%) | 0% | - | Common Stock | |
| Vyomesh I. Joshi | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 8.22 per share. | 13 May 2019 | 29,920 | 300,594 (0%) | 0% | 8.2 | 245,942 | Common Stock |
| Vyomesh I. Joshi | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.95 per share. | 01 Apr 2019 | 17,290 | 270,674 (0%) | 0% | 11.0 | 189,326 | Common Stock |
| Malissia R. Clinton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2019 | 2,424 | 2,424 (0%) | 0% | - | Common Stock | |
| Charles W. Hull | Director, EVP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2019 | 8,125 | 129,720 (0%) | 0% | 0 | Common Stock | |
| John N. McMullen | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2019 | 12,338 | 133,363 (0%) | 0% | 0 | Common Stock | |
| Vyomesh I. Joshi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2019 | 41,625 | 287,964 (0%) | 0% | 0 | Common Stock | |
| Kevin P. McAlea | EVP-COO, Healthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2019 | 12,207 | 279,305 (0%) | 0% | 0 | Common Stock | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2019 | 9,843 | 224,047 (0%) | 0% | 0 | Common Stock | |
| Herbert Koeck | EVP, Global Go To Market | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2019 | 12,594 | 72,040 (0%) | 0% | 0 | Common Stock | |
| Philip C. Schultz | EVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2019 | 10,158 | 87,543 (0%) | 0% | 0 | Common Stock | |
| Charles W. Hull | Director, EVP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2019 | 16,447 | 121,595 (0%) | 0% | 0 | Common Stock | |
| John N. McMullen | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2019 | 32,895 | 121,025 (0%) | 0% | 0 | Common Stock | |
| Vyomesh I. Joshi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2019 | 82,237 | 246,339 (0%) | 0% | 0 | Common Stock | |
| Kevin P. McAlea | EVP-COO, Healthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2019 | 23,757 | 267,098 (0%) | 0% | 0 | Common Stock | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2019 | 23,757 | 214,204 (0%) | 0% | 0 | Common Stock | |
| Herbert Koeck | EVP, Global Go To Market | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2019 | 23,757 | 59,446 (0%) | 0% | 0 | Common Stock | |
| Philip C. Schultz | EVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2019 | 25,585 | 77,385 (0%) | 0% | 0 | Common Stock | |
| Charles W. Hull | Director, EVP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.66 per share. | 13 Nov 2018 | 5,764 | 105,148 (0%) | 0% | 12.7 | 72,972 | Common Stock |
| Kevin P. McAlea | EVP-COO, Healthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.66 per share. | 13 Nov 2018 | 6,916 | 243,341 (0%) | 0% | 12.7 | 87,557 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.66 per share. | 13 Nov 2018 | 18,378 | 190,447 (0%) | 0% | 12.7 | 232,665 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 17.80 per share. | 24 Oct 2018 | 4,200 | 208,825 (0%) | 0% | 17.8 | 74,760 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 17.95 per share. | 04 Oct 2018 | 4,200 | 213,025 (0%) | 0% | 18.0 | 75,390 | Common Stock |
| Kevin P. McAlea | EVP-COO, Healthcare | Sale of securities on an exchange or to another person at price $ 21.21 per share. | 22 Aug 2018 | 20,000 | 250,257 (0%) | 0% | 21.2 | 424,200 | Common Stock |
| Charles W. Hull | Director, EVP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.87 per share. | 15 Aug 2018 | 2,629 | 110,912 (0%) | 0% | 18.9 | 49,609 | Common Stock |
| John N. McMullen | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.87 per share. | 15 Aug 2018 | 3,944 | 88,130 (0%) | 0% | 18.9 | 74,423 | Common Stock |
| Vyomesh I. Joshi | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.87 per share. | 15 Aug 2018 | 15,324 | 164,102 (0%) | 0% | 18.9 | 289,164 | Common Stock |
| Kevin P. McAlea | EVP-COO, Healthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.87 per share. | 15 Aug 2018 | 3,944 | 270,257 (0%) | 0% | 18.9 | 74,423 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 19.01 per share. | 15 Aug 2018 | 5,000 | 217,225 (0%) | 0% | 19.0 | 95,050 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.87 per share. | 15 Aug 2018 | 3,914 | 222,225 (0%) | 0% | 18.9 | 73,857 | Common Stock |
| Charles W. Hull | Director, EVP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.17 per share. | 26 Jul 2018 | 5,764 | 114,158 (0%) | 0% | 13.2 | 75,912 | Common Stock |
| Kevin P. McAlea | EVP-COO, Healthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.17 per share. | 26 Jul 2018 | 5,764 | 274,201 (0%) | 0% | 13.2 | 75,912 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.17 per share. | 26 Jul 2018 | 5,226 | 226,139 (0%) | 0% | 13.2 | 68,826 | Common Stock |
| G. Walter Loewenbaum | Director | Purchase of securities on an exchange or from another person at price $ 12.06 per share. | 29 May 2018 | 4,500 | 1,111,637 (0%) | 0% | 12.1 | 54,270 | Common Stock |
| Jeffrey Wadsworth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2018 | 6,007 | 56,855 (0%) | 0% | 0 | Common Stock | |
| Charles G. McClure | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2018 | 6,007 | 56,855 (0%) | 0% | 0 | Common Stock | |
| Jim D. Kever | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2018 | 7,758 | 326,986 (0%) | 0% | 0 | Common Stock | |
| John J. Tracy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2018 | 7,758 | 12,778 (0%) | 0% | 0 | Common Stock | |
| Jeffrey Wadsworth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2018 | 7,758 | 14,184 (0%) | 0% | 0 | Common Stock | |
| Kevin S. Moore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2018 | 7,758 | 101,029 (0%) | 0% | 0 | Common Stock | |
| Charles G. McClure | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2018 | 7,758 | 14,184 (0%) | 0% | 0 | Common Stock | |
| William D. Humes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2018 | 7,758 | 25,902 (0%) | 0% | 0 | Common Stock | |
| William E. Curran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2018 | 7,758 | 66,723 (0%) | 0% | 0 | Common Stock | |
| G. Walter Loewenbaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2018 | 7,758 | 1,093,940 (0%) | 0% | 0 | Common Stock | |
| Thomas W. Erickson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2018 | 7,758 | 81,514 (0%) | 0% | 0 | Common Stock | |
| G. Walter Loewenbaum | Director | Purchase of securities on an exchange or from another person at price $ 10.12 per share. | 07 May 2018 | 16,475 | 1,086,182 (0%) | 0% | 10.1 | 166,727 | Common Stock |
| Vyomesh I. Joshi | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.14 per share. | 02 Apr 2018 | 18,790 | 243,500 (0%) | 0% | 11.1 | 209,321 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.07 per share. | 05 Feb 2018 | 11,160 | 231,365 (0%) | 0% | 9.1 | 101,221 | Common Stock |
| G. Walter Loewenbaum | None | Purchase of securities on an exchange or from another person at price $ 9.33 per share. | 06 Dec 2017 | 1,000 | 1,069,707 (0%) | 0% | 9.3 | 9,330 | Common Stock |
| G. Walter Loewenbaum | None | Purchase of securities on an exchange or from another person at price $ 9.37 per share. | 05 Dec 2017 | 15,000 | 1,068,707 (0%) | 0% | 9.4 | 140,550 | Common Stock |
| Charles W. Hull | Director, EVP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2017 | 22,806 | 218,478 (0%) | 0% | 0 | Common Stock | |
| John N. McMullen | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2017 | 34,208 | 109,208 (0%) | 0% | 0 | Common Stock | |
| Vyomesh I. Joshi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2017 | 114,026 | 279,426 (0%) | 0% | 0 | Common Stock | |
| G. Walter Loewenbaum | None | Purchase of securities on an exchange or from another person at price $ 8.94 per share. | 04 Dec 2017 | 40,500 | 1,053,707 (0%) | 0% | 8.9 | 362,070 | Common Stock |
| Kevin P. McAlea | EVP-COO, Healthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2017 | 34,208 | 279,239 (0%) | 0% | 0 | Common Stock | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2017 | 27,081 | 242,525 (0%) | 0% | 0 | Common Stock | |
| G. Walter Loewenbaum | None | Purchase of securities on an exchange or from another person at price $ 8.81 per share. | 01 Dec 2017 | 6,430 | 1,013,207 (0%) | 0% | 8.8 | 56,648 | Common Stock |
| Charles W. Hull | Director, EVP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.34 per share. | 17 Nov 2017 | 13,546 | 195,672 (0%) | 0% | 8.3 | 112,974 | Common Stock |
| Kevin P. McAlea | EVP-COO, Healthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.34 per share. | 17 Nov 2017 | 16,933 | 245,031 (0%) | 0% | 8.3 | 141,221 | Common Stock |
| G. Walter Loewenbaum | None | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Aug 2017 | 5,100 | 0 (0%) | 0% | 0 | Common Stock | |
| G. Walter Loewenbaum | None | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Aug 2017 | 5,100 | 0 (0%) | 0% | 0 | Common Stock | |
| G. Walter Loewenbaum | None | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Aug 2017 | 3,000 | 1,006,777 (0%) | 0% | 0 | Common Stock | |
| Vyomesh I. Joshi | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 12.96 per share. | 08 Aug 2017 | 15,400 | 165,400 (0%) | 0% | 13.0 | 199,584 | Common Stock |
| Charles W. Hull | Director, EVP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.40 per share. | 26 Jul 2017 | 6,414 | 209,218 (0%) | 0% | 8.4 | 53,878 | Common Stock |
| Charles W. Hull | Director, EVP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.09 per share. | 26 Jul 2017 | 6,414 | 215,632 (0%) | 0% | 17.1 | 109,615 | Common Stock |
| Kevin P. McAlea | EVP-COO, Healthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.09 per share. | 26 Jul 2017 | 6,414 | 269,660 (0%) | 0% | 17.1 | 109,615 | Common Stock |
| Kevin P. McAlea | EVP-COO, Healthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.40 per share. | 26 Jul 2017 | 7,696 | 261,964 (0%) | 0% | 8.4 | 64,646 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.09 per share. | 26 Jul 2017 | 8,159 | 233,507 (0%) | 0% | 17.1 | 139,437 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.40 per share. | 26 Jul 2017 | 18,063 | 215,444 (0%) | 0% | 8.4 | 151,729 | Common Stock |
| John N. McMullen | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.09 per share. | 03 Jul 2017 | 8,646 | 92,074 (0%) | 0% | 14.1 | 121,822 | Common Stock |
| John N. McMullen | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.35 per share. | 03 Jul 2017 | 8,488 | 100,720 (0%) | 0% | 18.4 | 155,755 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 21.19 per share. | 08 Jun 2017 | 10,000 | 241,666 (0%) | 0% | 21.2 | 211,900 | Common Stock |
| John J. Tracy | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2017 | 5,020 | 5,020 (0%) | 0% | 0 | Common Stock | |
| Kevin P. McAlea | EVP-COO, Healthcare | Sale of securities on an exchange or to another person at price $ 20.63 per share. | 01 Jun 2017 | 17,500 | 276,074 (0%) | 0% | 20.6 | 361,025 | Common Stock |
| G. Walter Loewenbaum | None | Sale of securities on an exchange or to another person at price $ 21.50 per share. | 30 May 2017 | 25,000 | 982,106 (0%) | 0% | 21.5 | 537,500 | Common Stock |
| G. Walter Loewenbaum | None | Sale of securities on an exchange or to another person at price $ 22.29 per share. | 23 May 2017 | 25,000 | 1,007,106 (0%) | 0% | 22.3 | 557,250 | Common Stock |
| G. Walter Loewenbaum | None | Sale of securities on an exchange or to another person at price $ 22.50 per share. | 18 May 2017 | 14,704 | 1,042,402 (0%) | 0% | 22.5 | 330,840 | Common Stock |
| G. Walter Loewenbaum | None | Sale of securities on an exchange or to another person at price $ 21.66 per share. | 18 May 2017 | 10,296 | 1,032,106 (0%) | 0% | 21.7 | 223,011 | Common Stock |
| Jim D. Kever | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2017 | 4,290 | 319,228 (0%) | 0% | 0 | Common Stock | |
| Jeffrey Wadsworth | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2017 | 4,290 | 6,426 (0%) | 0% | 0 | Common Stock | |
| Kevin S. Moore | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2017 | 4,290 | 93,271 (0%) | 0% | 0 | Common Stock | |
| Charles G. McClure | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2017 | 4,290 | 6,426 (0%) | 0% | 0 | Common Stock | |
| William D. Humes | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2017 | 4,290 | 18,144 (0%) | 0% | 0 | Common Stock | |
| William E. Curran | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2017 | 4,290 | 58,965 (0%) | 0% | 0 | Common Stock | |
| G. Walter Loewenbaum | None | Gift of securities by or to the insider at price $ 0.00 per share. | 16 May 2017 | 10,000 | 1,057,106 (0%) | 0% | 0 | Common Stock | |
| G. Walter Loewenbaum | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2017 | 4,290 | 1,067,106 (0%) | 0% | 0 | Common Stock | |
| Thomas W. Erickson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2017 | 4,290 | 73,756 (0%) | 0% | 0 | Common Stock | |
| Vyomesh I. Joshi | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.14 per share. | 03 Apr 2017 | 19,240 | 243,050 (0%) | 0% | 11.1 | 214,334 | Common Stock |
| Vyomesh I. Joshi | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.94 per share. | 03 Apr 2017 | 17,136 | 262,290 (0%) | 0% | 14.9 | 256,012 | Common Stock |
| Jeffrey Wadsworth | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2017 | 2,136 | 2,136 (0%) | 0% | 0 | Common Stock | |
| Charles G. McClure | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2017 | 2,136 | 2,136 (0%) | 0% | 0 | Common Stock | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 14.70 per share. | 08 Mar 2017 | 4,000 | 251,666 (0%) | 0% | 14.7 | 58,800 | Common Stock |
| G. Walter Loewenbaum | None | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Mar 2017 | 239,475 | 0 (0%) | 0% | 0 | Common Stock | |
| G. Walter Loewenbaum | None | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Mar 2017 | 258,277 | 0 (0%) | 0% | 0 | Common Stock | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.61 per share. | 06 Feb 2017 | 9,932 | 255,666 (0%) | 0% | 16.6 | 164,971 | Common Stock |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Dec 2016 | 1,150 | 265,598 | - | - | Common Stock | |
| G. Walter Loewenbaum | None | Other type of transaction at price $ 0.00 per share. | 29 Nov 2016 | 144,530 | 176,944 | - | - | Common Stock | |
| Charles W. Hull | Director, EVP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 21 Nov 2016 | 9,471 | 222,046 | - | - | Common Stock | |
| Kevin P. McAlea | EVP-COO, Healthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 21 Nov 2016 | 4,636 | 293,574 | - | - | Common Stock | |
| Kevin P. McAlea | EVP-COO, Healthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 18 Nov 2016 | 6,790 | 298,210 | - | - | Common Stock | |
| Charles W. Hull | Director, EVP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 17 Nov 2016 | 5,659 | 231,517 | - | - | Common Stock | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 17 Nov 2016 | 15,121 | 266,748 | - | - | Common Stock | |
| Charles W. Hull | Director, EVP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2016 | 80,000 | 80,000 | - | - | Performance Based Stock Options (Right to Buy) | |
| Charles W. Hull | Director, EVP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2016 | 20,000 | 40,000 | - | - | Performance Based Restricted Stock | |
| Charles W. Hull | Director, EVP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2016 | 20,000 | 20,000 | - | - | Performance Based Restricted Stock | |
| Charles W. Hull | Director, EVP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2016 | 50,000 | 237,176 | - | - | Common Stock | |
| Charles W. Hull | Director, EVP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2016 | 80,000 | 160,000 | - | - | Performance Based Stock Options (Right to Buy) | |
| Kevin P. McAlea | EVP-COO, Healthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2016 | 20,000 | 40,000 | - | - | Performance Based Restricted Stock | |
| Kevin P. McAlea | EVP-COO, Healthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2016 | 80,000 | 80,000 | - | - | Performance Based Stock Options (Right to Buy) | |
| Kevin P. McAlea | EVP-COO, Healthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2016 | 80,000 | 160,000 | - | - | Performance Based Stock Options (Right to Buy) | |
| Kevin P. McAlea | EVP-COO, Healthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2016 | 20,000 | 20,000 | - | - | Performance Based Restricted Stock | |
| Kevin P. McAlea | EVP-COO, Healthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2016 | 50,000 | 305,000 | - | - | Common Stock | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2016 | 80,000 | 160,000 | - | - | Performance Based Stock Options (Right to Buy) | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2016 | 80,000 | 80,000 | - | - | Performance Based Stock Options (Right to Buy) | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2016 | 20,000 | 40,000 | - | - | Performance Based Restricted Stock | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2016 | 20,000 | 20,000 | - | - | Performance Based Restricted Stock | |
| Andrew M. Johnson | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2016 | 50,000 | 281,869 | - | - | Common Stock | |
| John N. McMullen | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2016 | 100,000 | 100,000 | - | - | Performance Based Stock Options (Right to Buy) |